PSYCHOPHYSIOLOGY, published by WILEY, stands as a leading journal in the intersection of psychology and physiology, contributing significantly to our understanding of the brain and body connection since its inception in 1964. With an impressive scope covering areas such as biological psychiatry, cognitive neuroscience, and neuropsychology among others, the journal has earned multiple Q1 rankings in these critical domains as of 2023, reflecting its high impact in the field. The journal ranks particularly well in categories such as Experimental and Cognitive Psychology and neurology, indicating its status as a pivotal resource for professionals and researchers committed to advancing knowledge in psychophysiological studies. Furthermore, with an e-ISSN of 1469-8986, PSYCHOPHYSIOLOGY is accessible to a global audience, although it is not part of the Open Access movement, ensuring that its rigorous research remains a trusted source for academic excellence. By engaging with this journal, readers can expect to discover pioneering research and significant findings that push the boundaries of current understanding, making it an essential publication for those invested in the advancements of psychological and physiological sciences.

NeuroImage-Clinical is a premier open access journal published by Elsevier Science Ltd, dedicated to advancing the field of clinical neuroimaging and its applications in a variety of neurological disorders. With an ISSN of 2213-1582, this journal has established itself as a leading source of innovative research since its inception in 2012, now continuing through 2024. Recognized for its high impact, it occupies the top quartile (Q1) in prestigious categories such as Cognitive Neuroscience, Neurology, and Radiology, affirming its relevance in clinical and research settings. Its Scopus rankings further exemplify its significant contribution to the disciplines of Radiology and Neurology, consistently placing it among the top tiers of journals in these fields. This journal not only provides critical insights for researchers and professionals but also serves as a valuable resource for students, fostering an understanding of the complexities in neuroimaging techniques and their implications for patient care. With open access options ensuring broad dissemination of knowledge, NeuroImage-Clinical plays a pivotal role in enhancing collaboration and innovation within the global neuroscience community.

Brain Connectivity is a premier journal dedicated to advancing the understanding of neural connections and brain function through innovative research and interdisciplinary collaboration. Published by MARY ANN LIEBERT, INC, this journal has established itself in the field of neuroscience, earning a respectable Q2 ranking in the 2023 category of Neuroscience (Miscellaneous) and a Scopus rank of 61 out of 113 in General Neuroscience. Since its inception in 2011, Brain Connectivity has been at the forefront of research on the intricate web of brain networks, exploring topics such as functional connectivity, neuroimaging, and the implications of connectivity studies for understanding various neurological disorders. Researchers, professionals, and students benefit from comprehensive access to cutting-edge studies and critical reviews, fostering a deeper appreciation of brain dynamics. As the field evolves, Brain Connectivity remains a vital resource for those aiming to contribute to our growing understanding of brain architecture and function.

EUROPEAN NEUROPSYCHOPHARMACOLOGY, published by Elsevier, is a prestigious academic journal that serves as a cornerstone in the field of neuropsychopharmacology, embracing multidisciplinary research at the intersection of neuroscience, psychiatry, and pharmacology. Since its establishment in 1990, this journal has consistently delivered cutting-edge research and reviews that drive forward our understanding of central nervous system disorders and their treatment. With an impressive impact factor and ranked in the Q1 category for several disciplines, including Biological Psychiatry and Neurology, it attracts submissions from leading researchers globally. The journal’s Scopus rankings reflect its significant influence, ranking in the top echelons across various categories such as Medicine and Neuroscience. While the journal maintains subscription access, readers are encouraged to explore the breadth of important findings that contribute to advancements in treatment options and improve patient care. EUROPEAN NEUROPSYCHOPHARMACOLOGY not only supports the dissemination of pivotal research but also fosters collaboration and dialogue within the scientific community, making it an essential resource for researchers, clinicians, and students dedicated to the complexities of brain health.

Alpha Psychiatry, published by AVES, stands at the forefront of mental health research and psychiatric advancements. With a commitment to disseminating high-quality and impactful studies, this journal serves as a critical platform for scholars, clinicians, and students interested in exploring the complexities of psychiatric disorders and treatment methodologies. Although the impact factor and specific scope details are still evolving, Alpha Psychiatry is dedicated to fostering interdisciplinary dialogue and promoting innovative research that tackles contemporary challenges in the field of psychiatry. As an open-access journal, it ensures that research is widely accessible, enhancing knowledge transfer and collaboration within the global scientific community. Located in Istanbul, Turkiye, the journal proudly represents a rich academic tradition, aiming to contribute significantly to the global discourse on mental health.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

HARVARD REVIEW OF PSYCHIATRY is a prestigious academic journal focused on the field of psychiatry and mental health, published by Lippincott Williams & Wilkins. Established in 1993, this journal has become a critical resource for researchers, clinicians, and students alike, providing cutting-edge insights and scholarly articles that address contemporary issues in mental health. With an impressive impact factor reflected in its Q1 ranking in Psychiatry and Mental Health, the journal ranks #90 out of 567 in its category in Scopus, placing it in the top 16% of publications in this field. The journal is dedicated to disseminating high-quality research and fostering dialogue among professionals, thus contributing significantly to the advancement of psychiatric sciences. Researchers can access the journal through traditional subscriptions, ensuring that vital knowledge and innovative practices are shared among a global audience.

Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

Neuropsychologia, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal that delves into the intersections of psychology and neuroscience, specifically focusing on behavioral and cognitive processes. Since its inception in 1963, this esteemed journal has been a vital platform for researchers, professionals, and students, showcasing innovative studies and advancements in the fields of Behavioral Neuroscience, Cognitive Neuroscience, and Experimental Psychology. With a commendable impact factor, placing it in the Q2 category across multiple disciplines, Neuropsychologia is recognized for its contribution to the scientific community, ranking among the top journals in both Experimental and Cognitive Psychology and Neuroscience. The journal's commitment to excellence is evident in its rigorous peer-review process and its mission to disseminate cutting-edge research, making it an invaluable resource for those seeking to expand their knowledge and insights in neuropsychology. For further reading, the journal is accessible in both print and digital formats, ensuring that researchers can easily engage with the latest findings and theoretical advancements in this dynamic field.